25 XP 0   0   10  
0coffee
Main menu
3rd party ad coffee SUPPORTERis ad-free.

AMBS (Amarantus) Stock Analysis
Buy, Hold or Sell?

Let's analyze Amarantus together

I guess you are interested in Amarantus Bioscience Holdings Inc. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

  • πŸ“Š Fundamental Analysis (FA) – Amarantus’s Financial Insights
  • πŸ“ˆ Technical Analysis (TA) – Amarantus’s Price Targets

I'm going to help you getting a better view of Amarantus Bioscience Holdings Inc. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

Get notifications about Amarantus Bioscience Holdings Inc

I send you an email if I find something interesting about Amarantus Bioscience Holdings Inc.

1. Quick Overview

1.1. Quick analysis of Amarantus (30 sec.)










1.2. What can you expect buying and holding a share of Amarantus? (30 sec.)

How much money do you get?

How much money do you get?
$0.00
When do you have the money?
1 year
How often do you get paid?
10.0%

What is your share worth?

Current worth
$-0.04
Expected worth in 1 year
$-0.07
How sure are you?
30.0%

+ What do you gain per year?

Total Gains per Share
$-0.03
Return On Investment
-6,014.2%

For what price can you sell your share?

Current Price per Share
$0.00
Expected price per share
$0.0005 - $0.0005
How sure are you?
50%
3rd party ad coffee SUPPORTERis ad-free.

2. Detailed Analysis

2.1. Valuation of Amarantus (5 min.)




Live pricePrice per Share (EOD)
$0.00
Intrinsic Value Per Share
$-0.17 - $-0.06
Total Value Per Share
$-0.21 - $-0.10

2.2. Growth of Amarantus (5 min.)




Is Amarantus growing?

Current yearPrevious yearGrowGrow %
How rich?-$24.6m-$19.9m-$4.7m-19.2%

How much money is Amarantus making?

Current yearPrevious yearGrowGrow %
Making money-$4.7m-$10.1m$5.4m114.1%
Net Profit Margin-4,995.5%0.0%--

How much money comes from the company's main activities?

2.3. Financial Health of Amarantus (5 min.)




2.4. Comparing to competitors in the Biotechnology industry (5 min.)




  Industry Rankings (Biotechnology)  

3rd party ad coffee SUPPORTERis ad-free.

3. Summary and Key Metrics

3.1. What can you expect buying and holding a share of Amarantus?

Welcome investor! Amarantus's management wants to use your money to grow the business. In return you get a share of Amarantus.

First you should know what it really means to hold a share of Amarantus. And how you can make/lose money.

Speculation

The Price per Share of Amarantus is $0.0005. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Amarantus.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Amarantus, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is $-0.04. Based on the TTM, the Book Value Change Per Share is $-0.01 per quarter. Based on the YOY, the Book Value Change Per Share is $-0.02 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is $0.00 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Amarantus.

How much money are you going to get?

 MRQTTMYOY5Y10Y
 $% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share
Usd Eps-0.01-1,510.9%-0.01-1,510.9%-0.02-3,234.8%0.00-494.5%-0.02-3,311.8%
Usd Book Value Change Per Share-0.01-1,503.6%-0.01-1,503.6%-0.02-3,312.9%0.00-421.9%0.00-670.6%
Usd Dividend Per Share0.000.0%0.000.0%0.000.0%0.000.0%0.00743.8%
Usd Total Gains Per Share-0.01-1,503.6%-0.01-1,503.6%-0.02-3,312.9%0.00-421.9%0.0073.2%
Usd Price Per Share0.00-0.00-0.02-0.01-0.10-
Price to Earnings Ratio-0.23--0.23--1.01--2.00--4.66-
Price-to-Total Gains Ratio-0.23--0.23--0.99--2.32--2.69-
Price to Book Ratio-0.04--0.04--0.52--0.49--7.40-
Price-to-Total Gains Ratio-0.23--0.23--0.99--2.32--2.69-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share0.0005
Number of shares2000000
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.000.00
Usd Book Value Change Per Share-0.010.00
Usd Total Gains Per Share-0.010.00
Gains per Quarter (2000000 shares)-15,035.54-4,218.62
Gains per Year (2000000 shares)-60,142.18-16,874.48
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
10-60142-601520-16874-16884
20-120284-1202940-33749-33758
30-180427-1804360-50623-50632
40-240569-2405780-67498-67506
50-300711-3007200-84372-84380
60-360853-3608620-101247-101254
70-420995-4210040-118121-118128
80-481137-4811460-134996-135002
90-541280-5412880-151870-151876
100-601422-6014300-168745-168750

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share0.01.00.00.0%0.03.00.00.0%1.04.00.020.0%1.09.00.010.0%1.014.00.06.7%
Book Value Change Per Share0.01.00.00.0%0.03.00.00.0%1.04.00.020.0%2.08.00.020.0%3.012.00.020.0%
Dividend per Share0.00.01.00.0%0.00.03.00.0%0.00.05.00.0%1.00.09.010.0%1.00.014.06.7%
Total Gains per Share0.01.00.00.0%0.03.00.00.0%1.04.00.020.0%3.07.00.030.0%4.011.00.026.7%
3rd party ad coffee SUPPORTERis ad-free.

3.2. Key Performance Indicators

The key performance indicators of Amarantus Bioscience Holdings Inc compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share---0.008-0.0080%-0.017+120%-0.002-72%-0.003-55%
Book Value Per Share---0.039-0.0390%-0.032-19%-0.029-26%-0.023-41%
Current Ratio--0.0010.0010%0.001-3%0.006-84%0.043-98%
Debt To Asset Ratio--3.4163.4160%2.355+45%3.505-3%3.227+6%
Debt To Equity Ratio----0%-0%-0%-0%
Dividend Per Share----0%-0%-0%0.004-100%
Enterprise Value---33801146.141-33801146.1410%-24293507.594-28%-26333670.204-22%38693179.942-187%
Eps---0.008-0.0080%-0.016+114%-0.002-67%-0.017+119%
Ev To Ebitda Ratio--7.0987.0980%2.383+198%12.193-42%1.811+292%
Ev To Sales Ratio---354.566-354.5660%inf+inf%inf+inf%nannan%
Free Cash Flow Per Share---0.007-0.0070%-0.016+121%-0.005-32%-0.008+13%
Free Cash Flow To Equity Per Share---0.007-0.0070%-0.016+122%-0.006-18%-0.002-66%
Gross Profit Margin--1.0001.0000%1.0000%1.057-5%1.101-9%
Intrinsic Value_10Y_max---0.065--------
Intrinsic Value_10Y_min---0.167--------
Intrinsic Value_1Y_max---0.005--------
Intrinsic Value_1Y_min---0.010--------
Intrinsic Value_3Y_max---0.017--------
Intrinsic Value_3Y_min---0.037--------
Intrinsic Value_5Y_max---0.029--------
Intrinsic Value_5Y_min---0.069--------
Market Cap315203.488-240%1071691.8591071691.8590%10338674.406-90%7464018.596-86%64553674.342-98%
Net Profit Margin---49.955-49.9550%--100%-11.488-77%-5.744-89%
Operating Margin---52.352-52.3520%--100%-12.522-76%-6.261-88%
Operating Ratio--3.8123.8120%-+100%2.660+43%1.330+187%
Pb Ratio-0.013+71%-0.043-0.0430%-0.519+1094%-0.494+1036%-7.398+16927%
Pe Ratio-0.066+71%-0.225-0.2250%-1.014+351%-2.003+790%-4.662+1972%
Price Per Share0.001-240%0.0020.0020%0.016-90%0.012-86%0.102-98%
Price To Free Cash Flow Ratio-0.070+71%-0.238-0.2380%-1.041+337%-12.236+5037%-15.706+6494%
Price To Total Gains Ratio-0.067+71%-0.226-0.2260%-0.990+338%-2.322+927%-2.686+1088%
Quick Ratio----0%0.000-100%0.000-100%0.023-100%
Return On Assets---0.467-0.4670%-0.693+49%-0.697+49%-2.732+486%
Return On Equity----0%-0%-0%-0%
Total Gains Per Share---0.008-0.0080%-0.017+120%-0.002-72%0.000-2155%
Usd Book Value---24665304.000-24665304.0000%-19926048.000-19%-18187006.600-26%-14481032.000-41%
Usd Book Value Change Per Share---0.008-0.0080%-0.017+120%-0.002-72%-0.003-55%
Usd Book Value Per Share---0.039-0.0390%-0.032-19%-0.029-26%-0.023-41%
Usd Dividend Per Share----0%-0%-0%0.004-100%
Usd Enterprise Value---33801146.141-33801146.1410%-24293507.594-28%-26333670.204-22%38693179.942-187%
Usd Eps---0.008-0.0080%-0.016+114%-0.002-67%-0.017+119%
Usd Free Cash Flow---4499307.000-4499307.0000%-9926805.000+121%-3058060.400-32%-5095717.700+13%
Usd Free Cash Flow Per Share---0.007-0.0070%-0.016+121%-0.005-32%-0.008+13%
Usd Free Cash Flow To Equity Per Share---0.007-0.0070%-0.016+122%-0.006-18%-0.002-66%
Usd Market Cap315203.488-240%1071691.8591071691.8590%10338674.406-90%7464018.596-86%64553674.342-98%
Usd Price Per Share0.001-240%0.0020.0020%0.016-90%0.012-86%0.102-98%
Usd Profit---4762305.000-4762305.0000%-10196279.000+114%-1558695.200-67%-9143666.600+92%
Usd Revenue--95331.00095331.0000%-+100%4034006.200-98%2017003.100-95%
Usd Total Gains Per Share---0.008-0.0080%-0.017+120%-0.002-72%0.000-2155%
 EOD+2 -6MRQTTM+0 -0YOY+18 -175Y+5 -3110Y+10 -27

3.3 Fundamental Score

Let's check the fundamental score of Amarantus Bioscience Holdings Inc based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-15-0.066
Price to Book Ratio (EOD)Between0-1-0.013
Net Profit Margin (MRQ)Greater than0-49.955
Operating Margin (MRQ)Greater than0-52.352
Quick Ratio (MRQ)Greater than10.000
Current Ratio (MRQ)Greater than10.001
Debt to Asset Ratio (MRQ)Less than13.416
Debt to Equity Ratio (MRQ)Less than10.000
Return on Equity (MRQ)Greater than0.150.000
Return on Assets (MRQ)Greater than0.05-0.467
Total1/10 (10.0%)

3.4 Technical Score

Let's check the technical score of Amarantus Bioscience Holdings Inc based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5099.322
Ma 20Greater thanMa 500.001
Ma 50Greater thanMa 1000.000
Ma 100Greater thanMa 2000.000
OpenGreater thanClose0.001
Total4/5 (80.0%)

4. In-depth Analysis

4.1 About Amarantus Bioscience Holdings Inc

Amarantus BioScience Holdings, Inc., a biopharmaceutical company, focuses on the development of diagnostic and therapeutic product candidates in the areas of neurology, psychiatry, ophthalmology, and regenerative medicine. The company's diagnostic products in development include the lymphocyte proliferation (LymPro) test, a diagnostic blood test for Alzheimer's disease; and MSPrecise, a proprietary DNA sequencing assay for the identification of patients with multiple sclerosis. Its therapeutic products in development comprise Eltoprazine, a small molecule drug for the treatment of Parkinson's disease Levadopa-Induced Dyskinesia and attention deficit hyperactivity disorders; and mesencephalic-astrocyte-derived neurotrophic factor for the treatment of various animal models, including retinitis pigmentosa and retinal artery occlusion. It also develops NuroPro, a neurodegenerative disease diagnostic platform with application in Parkinson's disease; BC-SeraPro, an oncology diagnostic platform with application in breast cancer; and PhenoGuard platform for neurrotrophic factor discovery. In addition, the company develops Engineered Skin Substitute (ESS), a cell therapy-based autologous skin replacement product that is in mid-stage clinical development for the treatment of life-threatening severe burns. Amarantus BioScience Holdings, Inc. has a cooperative research and development agreement with the U.S. Army Institute of Surgical Research and Rutgers University. The company was formerly known as Amarantus Bioscience, Inc. and changed its name to Amarantus BioScience Holdings, Inc. in April 2013. Amarantus BioScience Holdings, Inc. was founded in 2008 and is headquartered in New York, New York.

Fundamental data was last updated by Penke on 2025-03-28 07:53:03.

4.2 In-depth Summary

4.2.1. Financial Health Summary

Profitability Details
 Compared to previous yearCompared to industry
The company is making a huge loss.
Using its assets, the company is very inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is operating very inefficient.
The company is inefficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is unable to pay all its short-term debts.
Solvency Details
 Compared to previous yearCompared to industry
The company is unable to pay all its debts by selling its assets.

4.2.2. Valuation Summary

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is expensive.
Based on the earnings, the company is expensive.
Based on how much money comes from the company's main activities, the company is expensive.
3rd party ad coffee SUPPORTERis ad-free.

4.3 Financial Health

4.3.1. Profitability

4.3.1 Profitability
4.3.1.1. Net Profit Margin

Measures how much net profitΒ Amarantus earns for each $1 of revenue.

  • Above 10% is considered healthy but always compareΒ Amarantus to theΒ Biotechnology industry mean.
  • A Net Profit Margin of -4,995.5%Β means thatΒ $-49.96 for each $1Β in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Amarantus Bioscience Holdings Inc:

  • The MRQ is -4,995.5%. The company is making a huge loss. -2
  • The TTM is -4,995.5%. The company is making a huge loss. -2
Trends
Current periodCompared to+/- 
MRQ-4,995.5%TTM-4,995.5%0.0%
TTM-4,995.5%YOY--4,995.5%
TTM-4,995.5%5Y-1,148.8%-3,846.7%
5Y-1,148.8%10Y-574.4%-574.4%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-4,995.5%-88.1%-4,907.4%
TTM-4,995.5%-190.6%-4,804.9%
YOY--199.6%+199.6%
5Y-1,148.8%-336.0%-812.8%
10Y-574.4%-488.5%-85.9%
4.3.1.2. Return on Assets

Shows howΒ efficientΒ Amarantus is using its assets to generate profit.

  • Above 5% is considered healthyΒ but always compareΒ Amarantus to theΒ Biotechnology industry mean.
  • -46.7% Return on Assets means thatΒ Amarantus generatedΒ $-0.47 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Amarantus Bioscience Holdings Inc:

  • The MRQ is -46.7%. Using its assets, the company is very inefficient in making profit. -2
  • The TTM is -46.7%. Using its assets, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-46.7%TTM-46.7%0.0%
TTM-46.7%YOY-69.3%+22.7%
TTM-46.7%5Y-69.7%+23.0%
5Y-69.7%10Y-273.2%+203.5%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-46.7%-11.9%-34.8%
TTM-46.7%-11.9%-34.8%
YOY-69.3%-11.6%-57.7%
5Y-69.7%-12.7%-57.0%
10Y-273.2%-14.3%-258.9%
4.3.1.3. Return on Equity

Shows how efficient Amarantus is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compareΒ Amarantus to theΒ Biotechnology industry mean.
  • 0.0% Return on Equity means Amarantus generated $0.00Β for eachΒ $1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Amarantus Bioscience Holdings Inc:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.0%
TTM-YOY-0.0%
TTM-5Y-0.0%
5Y-10Y-0.0%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ--15.6%+15.6%
TTM--15.8%+15.8%
YOY--14.6%+14.6%
5Y--18.0%+18.0%
10Y--19.2%+19.2%
3rd party ad coffee SUPPORTERis ad-free.

4.3.2. Operating Efficiency of Amarantus Bioscience Holdings Inc.

4.3.2. Operating Efficiency
4.3.2.1. Operating Margin

MeasuresΒ how efficient Amarantus is operatingΒ .

  • Measures how much profit Amarantus makes for each $1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compareΒ Amarantus to theΒ Biotechnology industry mean.
  • An Operating Margin of -5,235.2%Β means the company generated $-52.35 Β for each $1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Amarantus Bioscience Holdings Inc:

  • The MRQ is -5,235.2%. The company is operating very inefficient. -2
  • The TTM is -5,235.2%. The company is operating very inefficient. -2
Trends
Current periodCompared to+/- 
MRQ-5,235.2%TTM-5,235.2%0.0%
TTM-5,235.2%YOY--5,235.2%
TTM-5,235.2%5Y-1,252.2%-3,983.1%
5Y-1,252.2%10Y-626.1%-626.1%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-5,235.2%-193.7%-5,041.5%
TTM-5,235.2%-296.4%-4,938.8%
YOY--206.9%+206.9%
5Y-1,252.2%-367.9%-884.3%
10Y-626.1%-475.9%-150.2%
4.3.2.2. Operating Ratio

Measures how efficient Amarantus is keepingΒ operating costsΒ low.

  • Below 1 is considered healthy (always compare toΒ Biotechnology industry mean).
  • An Operation Ratio of 3.81 means that the operating costs are $3.81 for each $1 in net sales.

Let's take a look of the Operating Ratio trends of Amarantus Bioscience Holdings Inc:

  • The MRQ is 3.812. The company is inefficient in keeping operating costs low. -1
  • The TTM is 3.812. The company is inefficient in keeping operating costs low. -1
Trends
Current periodCompared to+/- 
MRQ3.812TTM3.8120.000
TTM3.812YOY-+3.812
TTM3.8125Y2.660+1.152
5Y2.66010Y1.330+1.330
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ3.8122.025+1.787
TTM3.8123.215+0.597
YOY-2.982-2.982
5Y2.6604.689-2.029
10Y1.3306.513-5.183
3rd party ad coffee SUPPORTERis ad-free.

4.4.3. Liquidity of Amarantus Bioscience Holdings Inc.

4.4.3. Liquidity
4.4.3.1. Current Ratio

Measures if Amarantus is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare toΒ Biotechnology industry mean).
  • A Current Ratio of 0.00Β means the company has $0.00 in assets for each $1 in short-term debts.

Let's take a look of the Current Ratio trends of Amarantus Bioscience Holdings Inc:

  • The MRQ is 0.001. The company is unable to pay all its short-term debts. -2
  • The TTM is 0.001. The company is unable to pay all its short-term debts. -2
Trends
Current periodCompared to+/- 
MRQ0.001TTM0.0010.000
TTM0.001YOY0.0010.000
TTM0.0015Y0.006-0.005
5Y0.00610Y0.043-0.037
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.0013.616-3.615
TTM0.0013.879-3.878
YOY0.0014.483-4.482
5Y0.0065.950-5.944
10Y0.0436.240-6.197
4.4.3.2. Quick Ratio

Measures if Amarantus is able to pay off Short-term Debt but only usingΒ theΒ most liquid assets.

  • Above 1 is considered healthy butΒ always compareΒ Amarantus to theΒ Biotechnology industry mean.
  • A Quick Ratio of 0.00Β means the company can pay off $0.00 for each $1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Amarantus Bioscience Holdings Inc:

  • The MRQ is 0.000. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.000
TTM-YOY0.0000.000
TTM-5Y0.0000.000
5Y0.00010Y0.023-0.023
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-2.966-2.966
TTM-3.336-3.336
YOY0.0004.252-4.252
5Y0.0005.921-5.921
10Y0.0236.474-6.451
3rd party ad coffee SUPPORTERis ad-free.

4.5.4. Solvency of Amarantus Bioscience Holdings Inc.

4.5.4. Solvency
4.5.4.1. Debt to Asset Ratio

Measures how much %Β of AmarantusΒ assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compareΒ Amarantus to Biotechnology industry mean.
  • A Debt to Asset Ratio of 3.42Β means that Amarantus assets areΒ financed with 341.6% credit (debt) and the remaining percentage (100% - 341.6%)Β is financed by its owners/shareholders.Β 

Let's take a look of the Debt to Asset Ratio trends of Amarantus Bioscience Holdings Inc:

  • The MRQ is 3.416. The company is unable to pay all its debts by selling its assets. -2
  • The TTM is 3.416. The company is unable to pay all its debts by selling its assets. -2
Trends
Current periodCompared to+/- 
MRQ3.416TTM3.4160.000
TTM3.416YOY2.355+1.061
TTM3.4165Y3.505-0.089
5Y3.50510Y3.227+0.278
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ3.4160.340+3.076
TTM3.4160.340+3.076
YOY2.3550.312+2.043
5Y3.5050.359+3.146
10Y3.2270.382+2.845
4.5.4.2. Debt to Equity Ratio

Measures ifΒ Amarantus is able toΒ pay off its debts by usingΒ shareholders equity.

  • Below 2 is considered healthy butΒ always compareΒ Amarantus to theΒ Biotechnology industry mean.
  • A Debt to Equity ratio of 0.0% means that company has $0.00 debt for each $1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Amarantus Bioscience Holdings Inc:

  • The MRQ is 0.000. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.000
TTM-YOY-0.000
TTM-5Y-0.000
5Y-10Y-0.000
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-0.393-0.393
TTM-0.428-0.428
YOY-0.395-0.395
5Y-0.451-0.451
10Y-0.493-0.493
3rd party ad coffee SUPPORTERis ad-free.

4.6. Market Valuation

4.6.1. Earnings Per Share
4.6.2.1. Price to Earnings Ratio

MeasuresΒ how much money you payΒ for each share forΒ every $1 in earnings Amarantus generates.

  • Above 15 is considered overpriced butΒ always compareΒ Amarantus to theΒ Biotechnology industry mean.
  • A PE ratio of -0.23 means the investor is paying $-0.23Β for every $1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Amarantus Bioscience Holdings Inc:

  • The EOD is -0.066. Based on the earnings, the company is expensive. -2
  • The MRQ is -0.225. Based on the earnings, the company is expensive. -2
  • The TTM is -0.225. Based on the earnings, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-0.066MRQ-0.225+0.159
MRQ-0.225TTM-0.2250.000
TTM-0.225YOY-1.014+0.789
TTM-0.2255Y-2.003+1.778
5Y-2.00310Y-4.662+2.659
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD-0.066-2.074+2.008
MRQ-0.225-2.522+2.297
TTM-0.225-3.216+2.991
YOY-1.014-3.300+2.286
5Y-2.003-6.225+4.222
10Y-4.662-6.955+2.293
4.6.2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of Amarantus Bioscience Holdings Inc:

  • The EOD is -0.070. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The MRQ is -0.238. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The TTM is -0.238. Based on how much money comes from the company's main activities, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-0.070MRQ-0.238+0.168
MRQ-0.238TTM-0.2380.000
TTM-0.238YOY-1.041+0.803
TTM-0.2385Y-12.236+11.998
5Y-12.23610Y-15.706+3.470
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD-0.070-2.854+2.784
MRQ-0.238-3.511+3.273
TTM-0.238-3.835+3.597
YOY-1.041-4.297+3.256
5Y-12.236-8.217-4.019
10Y-15.706-9.311-6.395
3rd party ad coffee SUPPORTERis ad-free.
4.6.2. Book Value per Share
4.6.2.1. Price to Book Ratio

Measures if the stock price ofΒ Amarantus is to cheap or to expensiveΒ compared to its book value.

  • At or below 1 is considered healthyΒ (always compare to Biotechnology industry mean).
  • A PB ratio of -0.04 means the investor is paying $-0.04Β for each $1 in book value.

Let's take a look of the Price to Book Ratio trends of Amarantus Bioscience Holdings Inc:

  • The EOD is -0.013. Based on the equity, the company is expensive. -2
  • The MRQ is -0.043. Based on the equity, the company is expensive. -2
  • The TTM is -0.043. Based on the equity, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-0.013MRQ-0.043+0.031
MRQ-0.043TTM-0.0430.000
TTM-0.043YOY-0.519+0.475
TTM-0.0435Y-0.494+0.450
5Y-0.49410Y-7.398+6.905
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD-0.0131.874-1.887
MRQ-0.0432.120-2.163
TTM-0.0432.372-2.415
YOY-0.5192.453-2.972
5Y-0.4943.811-4.305
10Y-7.3984.584-11.982
4.6.2. Total Gains per Share
3rd party ad coffee SUPPORTERis ad-free.

6. Financial Statements




6.1. Latest Balance Sheet

Balance Sheet of 2022-12-31. All numbers in thousands.

Summary
Total Assets10,208
Total Liabilities34,873
Total Stockholder Equity-24,665
 As reported
Total Liabilities 34,873
Total Stockholder Equity+ -24,665
Total Assets = 10,208

Assets

Total Assets10,208
Total Current Assets31
Long-term Assets10,177
Total Current Assets
Other Current Assets 31
Total Current Assets  (as reported)31
Total Current Assets  (calculated)31
+/-0
Long-term Assets
Intangible Assets 1
Long-term Assets  (as reported)10,177
Long-term Assets  (calculated)1
+/- 10,176

Liabilities & Shareholders' Equity

Total Current Liabilities34,873
Long-term Liabilities0
Total Stockholder Equity-24,665
Total Current Liabilities
Short-term Debt 19,139
Accounts payable 15,309
Other Current Liabilities 424
Total Current Liabilities  (as reported)34,873
Total Current Liabilities  (calculated)34,873
+/-0
Long-term Liabilities
Long-term Liabilities  (as reported)0
Long-term Liabilities  (calculated)0
+/-0
Total Stockholder Equity
Common Stock293
Retained Earnings -106,474
Other Stockholders Equity 80,276
Total Stockholder Equity (as reported)-24,665
Total Stockholder Equity (calculated)-25,905
+/- 1,240
Other
Common Stock Shares Outstanding 579,607
Liabilities and Stockholders Equity 10,208
Net Debt 19,139
Net Working Capital -34,842
Short Long Term Debt Total 19,139



6.2. Balance Sheets Structured

All numbers in thousands.

 Trend2022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-312015-12-312014-12-312013-12-312012-12-312011-12-312010-12-312009-12-312008-12-31
> Total Assets 
8
4
3
355
1,210
1,859
2,258
11,771
11,134
10,238
3,483
24,786
24,873
14,707
10,208
10,20814,70724,87324,7863,48310,23811,13411,7712,2581,8591,210355348
   > Total Current Assets 
3
0
1
336
677
1,248
412
828
2,317
1,438
755
31
31
31
31
313131317551,4382,3178284121,248677336103
       Cash And Cash Equivalents 
3
0
1
1
157
1,033
214
176
49
47
1
1
0
1
0
0101147491762141,0331571103
       Short-term Investments 
0
0
0
0
0
0
97
0
0
0
0
0
0
0
0
0000000097000000
       Net Receivables 
0
0
0
0
0
0
0
0
639
599
34
0
0
0
0
00003459963900000000
       Other Current Assets 
0
0
0
335
111
0
0
567
1,628
793
720
31
31
31
31
313131317207931,62856700111335000
   > Long-term Assets 
5
4
2
18
533
611
1,846
10,943
8,817
8,800
2,728
24,754
24,842
14,675
10,177
10,17714,67524,84224,7542,7288,8008,81710,9431,84661153318245
       Property Plant Equipment 
5
4
2
18
0
0
145
115
17
0
0
0
0
0
0
000000171151450018245
       Goodwill 
0
0
0
0
0
0
0
7,967
0
0
0
0
0
0
0
00000007,9670000000
       Long Term Investments 
0
0
0
0
0
0
0
0
8,800
8,800
2,727
0
0
0
0
00002,7278,8008,80000000000
       Intangible Assets 
0
0
0
0
532
611
1,497
2,861
0
0
1
1
1
1
1
11111002,8611,4976115320000
       Other Assets 
0
0
0
0
1
0
204
0
0
0
0
0
0
0
0
00000000204010000
> Total Liabilities 
4
20
78
3,705
4,738
9,378
6,329
20,459
26,714
28,255
31,387
33,741
34,357
34,633
34,873
34,87334,63334,35733,74131,38728,25526,71420,4596,3299,3784,7383,70578204
   > Total Current Liabilities 
4
20
78
3,543
4,738
8,539
6,329
16,192
26,714
28,255
31,387
33,741
34,357
34,633
34,873
34,87334,63334,35733,74131,38728,25526,71416,1926,3298,5394,7383,54378204
       Short-term Debt 
0
12
13
864
1,509
1,056
0
2,919
11,449
10,674
18,655
19,138
19,201
19,193
19,139
19,13919,19319,20119,13818,65510,67411,4492,91901,0561,50986413120
       Short Long Term Debt 
0
0
0
0
769
43
222
3,141
10,974
10,199
0
0
0
0
0
0000010,19910,9743,141222437690000
       Accounts payable 
4
0
0
2,053
2,597
971
5,903
7,723
15,265
17,581
12,732
14,604
15,156
15,440
15,309
15,30915,44015,15614,60412,73217,58115,2657,7235,9039712,5972,053004
       Other Current Liabilities 
0
9
66
326
482
5,859
426
5,098
475
0
0
-14,604
-15,156
-15,440
424
424-15,440-15,156-14,604004755,0984265,8594823266690
   > Long-term Liabilities 
0
0
0
162
0
839
0
4,267
0
0
0
0
0
0
0
00000004,26708390162000
       Other Liabilities 
0
0
0
98
0
0
0
1,113
0
0
0
0
0
0
0
00000001,11300098000
       Deferred Long Term Liability 
0
0
0
0
0
0
0
1,113
0
0
0
0
0
0
0
00000001,1130000000
> Total Stockholder Equity
4
-16
-75
-3,350
-3,528
-7,519
-4,071
-8,688
-15,580
-18,017
-27,904
-8,956
-9,484
-19,926
-24,665
-24,665-19,926-9,484-8,956-27,904-18,017-15,580-8,688-4,071-7,519-3,528-3,350-75-164
   Common Stock
11
11
11
81
343
574
842
21
19,469
19,604
224
261
272
282
293
29328227226122419,60419,4692184257434381111111
   Retained Earnings -106,474-101,652-91,247-90,619-115,598-119,601-103,521-92,241-55,183-27,032-11,862-6,726-102-43-23
   Capital Surplus 000000000000000
   Treasury Stock000000000000000
   Other Stockholders Equity 
16
16
16
3,296
7,991
18,938
45,050
74,767
80,054
81,961
84,834
80,110
80,230
80,193
80,276
80,27680,19380,23080,11084,83481,96180,05474,76745,05018,9387,9913,296161616



6.3. Balance Sheets

All numbers in thousands.




6.4. Cash Flows

All numbers in thousands.




6.5. Income Statements

All numbers in thousands.


6.6. Latest Income Statement

Income Statement (annual), 2022-12-31. All numbers in thousands.

Gross Profit (+$)
totalRevenue95
Cost of Revenue-0
Gross Profit9595
 
Operating Income (+$)
Gross Profit95
Operating Expense-363
Operating Income-268-268
 
Operating Expense (+$)
Research Development0
Selling General Administrative0
Selling And Marketing Expenses0
Operating Expense3630
 
Net Interest Income (+$)
Interest Income0
Interest Expense-0
Other Finance Cost-0
Net Interest Income0
 
Pretax Income (+$)
Operating Income-268
Net Interest Income0
Other Non-Operating Income Expenses0
Income Before Tax (EBT)-4,7624,226
EBIT - interestExpense = -4,991
-4,991
-4,762
Interest Expense0
Earnings Before Interest and Taxes (EBIT)-4,991-4,762
Earnings Before Interest and Taxes (EBITDA)-4,762
 
After tax Income (+$)
Income Before Tax-4,762
Tax Provision-0
Net Income From Continuing Ops0-4,762
Net Income-4,762
Net Income Applicable To Common Shares0
 
Non-recurring Events
Discontinued Operations0
Extraordinary Items0
Effect of Accounting Charges0
Other Items0
Non Recurring0
Other Operating Expenses363
Total Other Income/Expenses Net-4,4940
 

Technical Analysis of Amarantus
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of Amarantus. The general trend of Amarantus is BULLISH with 71.4% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine Amarantus's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator zone transitionsBullish trend (71.4%) Bearish trend (-71.4%)
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Amarantus Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

SupportΒ is a price level at which demand for an asset is strong enough to prevent the price from falling further.
ResistanceΒ is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of Amarantus Bioscience Holdings Inc.

The long score for the Support & Resistance is 1/1.
The longshort score for the Support & Resistance is 1/(-1 +1).

  • Around support: The price is currently trading around a support level. This can be considered as a potential entry level. +1

The bullish price targets are: 0.0005 < 0.0005 < 0.0005.

The bearish price targets are: 0.0005 > 0.0005 > 0.0005.

Know someone who trades $AMBS? Share this with them.πŸ‘‡

Amarantus Bioscience Holdings Inc Daily Support & Resistance Chart
3rd party ad coffee SUPPORTERis ad-free.

2. Trend Indicators

2.1 Moving Averages

Shows theΒ moving averageΒ of the selected period.

  • Moving averages are laggingΒ trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of Amarantus Bioscience Holdings Inc. The current mas is .

The long score for the Moving Averages is 12/14.
The longshort score for the Moving Averages is 10/(-14 +14).

  • MA 20 trending down: The MA 20 is trending down. -1
  • Close < MA 20: The price is below the MA 20. -1
  • MA 20 > MA 50: The MA 20 is higher than the MA 50. +1
  • MA 20 > MA 100: The MA 20 is higher than the MA 100. +1
  • MA 20 > MA 200: The MA 20 is higher than the MA 200. +1
  • MA 50 trending up: The MA 50 is trending up. +1
  • Close > MA 50: The price is above the MA 50. +1
  • MA 50 > MA 100: The MA 50 is higher than the MA 100. +1
  • MA 50 > MA 200: The MA 50 is higher than the MA 200. +1
  • MA 100 trending up: The MA 100 is trending up. +1
  • Close > MA 100: The price is above the MA 100. +1
  • MA 100 > MA 200: The MA 100 is higher than the MA 200. +1
  • MA 200 trending up: The MA 200 is trending up. +1
  • Close > MA 200: The price is above the MA 200. +1

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200
MA 2020
MA 5050-
MA 100100--
MA 200200---

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

Amarantus Bioscience Holdings Inc Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows theΒ momentumΒ of theΒ selected period based on two moving averages.

  • MACD is aΒ lagging momentumΒ indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of Amarantus Bioscience Holdings Inc. The current macd is 0.000059.

The long score for the Moving Average Convergence/Divergence (MACD) is 1/4.
The longshort score for the Moving Average Convergence/Divergence (MACD) is -2/(-4 +4).

  • MACD line < signal line: The MACD line is below the signal line, which indicates a bearish signal in the market. This means that the negative momentum is currently stronger than the average momentum, suggesting that sellers are more active than buyers, and there's a higher probability of the Amarantus price going down in the near term. -2
  • MACD > 0: The MACD is above the zero line (centerline), it indicates a bullish signal for Amarantus. This means that the short-term moving average is higher than the long-term moving average, signaling positive momentum and suggesting a higher likelihood of the Amarantus price continuing to rise in the near future. It indicates that buyers are gaining control, and there is optimism in the market, leading to potential price increases. +1
  • Trending down: The MACD line is trending down. This indicates that the short-term moving average is falling faster than the long-term moving average, suggesting negative momentum in the market. This signals that sellers are becoming more active and insecure, leading to potential price decreases as traders anticipate further losses and are willing to sell at lower prices. -1
Amarantus Bioscience Holdings Inc Daily Moving Average Convergence/Divergence (MACD) ChartAmarantus Bioscience Holdings Inc Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of Amarantus Bioscience Holdings Inc. The current adx is 96.56.

The long score for the Directional Movement Index (DMI) is 4/7.
The longshort score for the Directional Movement Index (DMI) is 4/(-7 +7).

  • PLUS_ID > MINUS_DI: The +DI line is above the -DI line. This indicates a bullish signal in the market, as the positive directional movement is currently stronger than the negative directional movement, showing that buyers have the upper hand. Market psychology suggests that traders are optimistic, expecting further price increases, and are more willing to buy Amarantus shares, leading to potential upward momentum in its price. +1
  • PLUS_ID > MINUS_DI && ADX > 25 && ADX trending up: The ADX is above 25 and indicates a strong bullish trend. The ADX is trending up, so the bullish trend is strengthening.
Amarantus Bioscience Holdings Inc Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • ShowsΒ the current trend.
  • ShowsΒ potential entry signals.
  • ShowsΒ Β potential exit signals.
  • Can be used to placeΒ trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of Amarantus Bioscience Holdings Inc. The current sar is 0.00409791.

The long score for the Parabolic SAR is 0/1.
The longshort score for the Parabolic SAR is -1/(-1 +1).

  • Close < SAR: The price is below the SAR. It's generally considered a bearish signal. -1
Amarantus Bioscience Holdings Inc Daily Parabolic SAR Chart
3rd party ad coffee SUPPORTERis ad-free.

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentumΒ indicator, meaning the signals are instant.
  • RangesΒ between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of Amarantus Bioscience Holdings Inc. The current rsi is 99.32. The current phase is Overbought in bull market.

The long score for the Relative Strength Index (RSI) is 0/13.
The longshort score for the Relative Strength Index (RSI) is -1/(-13 +13).

  • Overbought in bull market: Short-term excessive buying, potential for pullback. Consider taking profits, be cautious of potential correction. -1
Amarantus Bioscience Holdings Inc Daily Relative Strength Index (RSI) ChartAmarantus Bioscience Holdings Inc Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

ComparesΒ a certain price to multiple prices ranging over time.

  • LeadingΒ momentumΒ indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • RangesΒ between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of Amarantus Bioscience Holdings Inc. The current phase is Oversold in bull market.

The long score for the Stochastic Oscillator is 0/6.
The longshort score for the Stochastic Oscillator is -6/(-6 +6).

  • STOCH < 50: The STOCH %K is below 50. There are more sellers than buyers. -1
  • STOCH < 20: The STOCH %K is below 20 and oversold. -2
  • STOCH %K line < STOCH %D line: The STOCH %K line is below the STOCH %D line, which indicates a bearish signal in the market. This means that the negative momentum is currently stronger than the average momentum, suggesting that sellers are more active than buyers, and there's a higher probability of the Amarantus price going down in the near term. -2
  • Trending down: The STOCH %K is trending down. -1
Amarantus Bioscience Holdings Inc Daily Stochastic Oscillator ChartAmarantus Bioscience Holdings Inc Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero,Β the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of Amarantus Bioscience Holdings Inc. The current cci is -66.66666667.

Amarantus Bioscience Holdings Inc Daily Commodity Channel Index (CCI) ChartAmarantus Bioscience Holdings Inc Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of Amarantus Bioscience Holdings Inc. The current cmo is 99.97.

The long score for the Chande Momentum Oscillator (CMO) is 1/1.
The longshort score for the Chande Momentum Oscillator (CMO) is 1/(-1 +1).

  • CMO > 0: The CMO is above 0, the momentum of the price is positive, indicating a potential uptrend in the price. +1
Amarantus Bioscience Holdings Inc Daily Chande Momentum Oscillator (CMO) ChartAmarantus Bioscience Holdings Inc Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

Β Shows the current price relative to the highest high over the last 14 days.
Β 

  • Lagging momentum indicator
  • Ranging between 0 andΒ -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of Amarantus Bioscience Holdings Inc. The current willr is 0.

The long score for the Williams %R is 1/1.
The longshort score for the Williams %R is 1/(-1 +1).

  • WILLR > -20: The Williams %R is above -20. This indicates that the price is in overbought territory, suggesting a potential price correction or trend reversal to the downside. +1
Amarantus Bioscience Holdings Inc Daily Williams %R ChartAmarantus Bioscience Holdings Inc Daily Williams %R Chart
3rd party ad coffee SUPPORTERis ad-free.

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversoldΒ 

Score

Let's take a look at the Bollinger Bands of Amarantus Bioscience Holdings Inc.

Amarantus Bioscience Holdings Inc Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of Amarantus Bioscience Holdings Inc. The current atr is 0.000010.

Amarantus Bioscience Holdings Inc Daily Average True Range (ATR) ChartAmarantus Bioscience Holdings Inc Daily Average True Range (ATR) Chart
3rd party ad coffee SUPPORTERis ad-free.

5. Volume Indicators

5.1 On-Balance Volume (OBV)

Β Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of Amarantus Bioscience Holdings Inc. The current obv is -12,813,375.

Amarantus Bioscience Holdings Inc Daily On-Balance Volume (OBV) ChartAmarantus Bioscience Holdings Inc Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of Amarantus Bioscience Holdings Inc. The current mfi is 0.

The long score for the Money Flow Index (MFI) is 0/2.
The longshort score for the Money Flow Index (MFI) is -2/(-2 +2).

  • MFI < 50: -1
  • MFI < 20: -1
Amarantus Bioscience Holdings Inc Daily Money Flow Index (MFI) ChartAmarantus Bioscience Holdings Inc Daily Money Flow Index (MFI) Chart
3rd party ad coffee SUPPORTERis ad-free.

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for Amarantus Bioscience Holdings Inc.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2024-11-06STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-11-11MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-11-21BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-11-25MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2025-02-21CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2025-02-24CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-02-26STOCH LONG EXITThe %K line crosses below the %D line.
2025-03-14MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2025-03-20BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.

6.3. Candlestick Patterns

Amarantus Bioscience Holdings Inc Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of Amarantus Bioscience Holdings Inc based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5099.322
Ma 20Greater thanMa 500.001
Ma 50Greater thanMa 1000.000
Ma 100Greater thanMa 2000.000
OpenGreater thanClose0.001
Total4/5 (80.0%)
Penke
Good job! You gained 25 XP and 0   0   10 . What's next:
  • Share my analysis of Amarantus with someone you think should read this too:
  • Are you bullish or bearish on Amarantus? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about Amarantus? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about Amarantus Bioscience Holdings Inc

I send you an email if I find something interesting about Amarantus Bioscience Holdings Inc.


Comments

How you think about this?

Leave a comment

Stay informed about Amarantus Bioscience Holdings Inc.

Receive notifications about Amarantus Bioscience Holdings Inc in your mailbox!

3rd party ad coffee SUPPORTERis ad-free.